212 related articles for article (PubMed ID: 33586661)
21. Dupilumab as promising treatment for prurigo nodularis: current evidences.
Toffoli L; Farinazzo E; Zelin E; Agozzino M; Dianzani C; Di Meo N; Nan K; Zalaudek I; Conforti C
J Dermatolog Treat; 2022 May; 33(3):1306-1311. PubMed ID: 33588666
[TBL] [Abstract][Full Text] [Related]
22. Dupilumab effectiveness in a case of prurigo nodularis and severe recalcitrant hidradenitis suppurativa.
Caposiena Caro RD; Bazzacco G; Zelin E; Mazzoletti V; Agozzino M; Signoretto D; DI Meo N; Zalaudek I
Ital J Dermatol Venerol; 2024 Jun; 159(3):370-371. PubMed ID: 38619203
[No Abstract] [Full Text] [Related]
23. Effectiveness of Dupilumab in Pediatric Patient With Prurigo Nodularis-Like Atopic Dermatitis.
Yiling Y; Ali K; Jiayang D; Qiu Y; Kai G; JinPeng S; Tianci X; Min C; Menghua L; Liming W
Dermatitis; 2023; 34(2):162-163. PubMed ID: 36917530
[No Abstract] [Full Text] [Related]
24. [THREE CASES OF ATOPIC DERMATITIS CHILDREN WITH INTRACTABLE PRURIGO NODULARIS].
Murakami Y; Sugiyama A; Ideguchi H; Murakami Y; Amimoto Y; Nishie H; Odajima H
Arerugi; 2020; 69(3):213-217. PubMed ID: 32435023
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of dupilumab in prurigo nodularis in elderly patient.
Giura MT; Viola R; Fierro MT; Ribero S; Ortoncelli M
Dermatol Ther; 2020 Jan; 33(1):e13201. PubMed ID: 31856368
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of Dupilumab for the Treatment of Generalized Prurigo Nodularis Phenotype of Adult Atopic Dermatitis.
Napolitano M; Fabbrocini G; Scalvenzi M; Nisticò SP; Dastoli S; Patruno C
Dermatitis; 2020; 31(1):81-84. PubMed ID: 31517666
[TBL] [Abstract][Full Text] [Related]
27. New Dupilumab Indication for Rare Skin Disease.
Aschenbrenner DS
Am J Nurs; 2023 Feb; 123(2):26-27. PubMed ID: 36698357
[TBL] [Abstract][Full Text] [Related]
28. A real-world observational study of dupilumab treatment in adult patients with prurigo nodularis.
Zhang Z; Li S; Wang Y; Zhao J
An Bras Dermatol; 2023; 98(4):440-448. PubMed ID: 36966024
[TBL] [Abstract][Full Text] [Related]
29. Our experience with prurigo nodularis treated with dupilumab.
Tilotta G; Pistone G; Caruso P; Gurreri R; Castelli E; Curiale S; Caputo V; Bongiorno MR
J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):e285-e287. PubMed ID: 33232536
[No Abstract] [Full Text] [Related]
30. Long-term dupilumab treatment for chronic refractory generalized prurigo nodularis: A retrospective cohort study.
Georgakopoulos JR; Croitoru D; Felfeli T; Alhusayen R; Lansang P; Shear NH; Yeung J; Walsh S
J Am Acad Dermatol; 2021 Oct; 85(4):1049-1051. PubMed ID: 33617911
[No Abstract] [Full Text] [Related]
31. Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.
Ständer S; Yosipovitch G; Legat FJ; Lacour JP; Paul C; Narbutt J; Bieber T; Misery L; Wollenberg A; Reich A; Ahmad F; Piketty C
N Engl J Med; 2020 Feb; 382(8):706-716. PubMed ID: 32074418
[TBL] [Abstract][Full Text] [Related]
32. Dupilumab in Treatment of Chronic Prurigo: A Case Series and Literature Review.
Almustafa ZZ; Weller K; Autenrieth J; Maurer M; Metz M
Acta Derm Venereol; 2019 Sep; 99(10):905-906. PubMed ID: 31233177
[No Abstract] [Full Text] [Related]
33. Effectiveness of dupilumab for chronic prurigo in elderly patients with atopic dermatitis.
Mitsuyama S; Higuchi T
An Bras Dermatol; 2023; 98(1):86-89. PubMed ID: 36376117
[No Abstract] [Full Text] [Related]
34. Dupilumab Treatment for Prurigo Nodularis and Pruritis.
Tanis R; Ferenczi K; Payette M
J Drugs Dermatol; 2019 Sep; 18(9):940-942. PubMed ID: 31524352
[TBL] [Abstract][Full Text] [Related]
35. Dupilumab (Dupixent) for eosinophilic esophagitis and prurigo nodularis.
Med Lett Drugs Ther; 2023 Feb; 65(1669):18-20. PubMed ID: 36757348
[No Abstract] [Full Text] [Related]
36. Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo.
Chiricozzi A; Maurelli M; Gori N; Argenziano G; De Simone C; Calabrese G; Girolomoni G; Peris K
J Am Acad Dermatol; 2020 Jul; 83(1):39-45. PubMed ID: 32229281
[TBL] [Abstract][Full Text] [Related]
37. Chronic Prurigo.
Thünemann J; Müller S; Steinbrink K; Ständer S; Zeidler C
J Dtsch Dermatol Ges; 2024 Jun; 22(6):813-823. PubMed ID: 38722190
[TBL] [Abstract][Full Text] [Related]
38. Clearance of pediatric actinic prurigo with dupilumab.
Eickstaedt JB; Starke S; Krakora D; Hinshaw M; Arkin LM
Pediatr Dermatol; 2020 Nov; 37(6):1176-1178. PubMed ID: 32869345
[TBL] [Abstract][Full Text] [Related]
39. Dupilumab Treatment for Generalized Prurigo Nodularis.
Beck KM; Yang EJ; Sekhon S; Bhutani T; Liao W
JAMA Dermatol; 2019 Jan; 155(1):118-120. PubMed ID: 30427994
[No Abstract] [Full Text] [Related]
40. Reduced Itch Associated With Dupilumab Treatment In 4 Patients With Prurigo Nodularis.
Mollanazar NK; Elgash M; Weaver L; Valdes-Rodriguez R; Hsu S
JAMA Dermatol; 2019 Jan; 155(1):121-122. PubMed ID: 30427989
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
